NCT07649577Completed
Generative AI for Medication Counselling and Adherence in Community Pharmacies
Human-AI Collaboration in the Pharmacy: A Cluster Randomized Controlled Trial of Generative AI for Medication Counselling and Adherence
Source: ClinicalTrials.gov · Last updated 16 Jun 2026
Brief summary (registry, in English)
Medication counseling within community pharmacies is crucial for managing chronic diseases, yet significant challenges regarding correctness and completeness remain in Jordan. Although generative artificial intelligence (AI) can be utilized for patient education, there is a lack of research on clinical impact and safety of AI in medication counseling conducted by pharmacists in real-world practice. The aim of this study is to evaluate the effect of pharmacist-supervised AI-assisted medication counseling on the correctness and completeness of counseling information and 30-day medication adherence among patients in Jordanian community pharmacies.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 136 (actual)
- First submitted
- 3 Jun 2026
- Start date
- Jan 2026
- Primary completion date
- Mar 2026
- Lead sponsor
- University of Petra
- Diseases
- Asthma, COPD, High blood pressure
- NCT number
- NCT07649577
What you commit to
- Study type: Interventional
- Participants enrolled: 136
- From Jan 2026 to the primary completion date, Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of acute infections. Diagnosis of psychiatric disorders or oncological conditions. Presence of severe acute illness requiring urgent medical referral. Cognitive impairment precluding informed consent. Hearing or communication barriers that prevent interview completion without the presence of a caregiver.
Other
- Inability to provide a follow-up phone number for the 30-day adherence assessment.
- Pharmacy and Pharmacist (Cluster) Eligibility Criteria
- Pharmacies that are already using structured AI-assisted counseling tools as part of their routine practice.
- Pharmacists on temporary placement for less than one month. Pharmacists not involved in patient-facing counseling.
Who the study is looking for
- Adults aged 18 years or older. Presenting with a new prescription or a refill for a chronic medication requiring counseling within one of the following classes: antihypertensives, oral antidiabetics, lipid-lowering agents, anticoagulants, or inhaled maintenance therapies.
- Willing and able to provide informed consent.
- Pharmacies legally registered in Jordan, providing routine prescription dispensing services, having at least one licensed pharmacist available during recruitment hours, and agreeing to participate for the full trial period.
- Licensed pharmacists with a minimum of 2 years of clinical experience, working in participating pharmacies, providing direct patient counseling, and consenting to take part in the study.
Criteria the registry did not label
- Patient Eligibility Criteria
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Petra University Coordinator of this site? Confirm its status | Amman | Jordan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.